For many individuals in recovery from alcohol and substance addiction, and their families, one of the most pressing questions is: How long is drug rehab? The truth is, there is no definitive answer.

Since 2019, three disease-specific therapies have been approved to treat patients with ATTR-CM. The first was Pfizer’s Vyndamax (tafamidis) in May 2019, which was approved for both wild type and ...